Clinical Trial Update: Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study [Phase 2]

View source ↗

Summary

A randomized Phase II trial evaluating autologous dendritic cell vaccines loaded with patient tumor lysate, with immunomodulating radiotherapy and/or interferon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma of the Skin

Drugs mentioned

• Autologous dendritic cell vaccine loaded with autologous tumor lysate/homogenate (autologous dendritic cell vaccine)
• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Malignant Melanoma of Skin Stage III, Malignant Melanoma of Skin Stage IV | Phase 2 | Status: COMPLETED